Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dolomite to Showcase Novel Microfluidic Solutions at MicroTAS 2013

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
Telos and Mitos Dropix to be showcased in Germany from 27th to 31st October.

Dolomite will be showcasing two devices, Telos and Mitos Dropix, on booth #6 at the 17th International Systems for Chemistry and Life Sciences (MicroTAS) in Freiburg, Germany, from the 27th to the 31st October.

The innovative Telos System is a breakthrough product for a wide range of industries requiring a microfluidic device capable of high throughput droplet, particle and flow product generation.

This modular, scalable, and highly flexible technology removes the low throughput limitation of individual microfluidic chips, enabling liters of droplets or particles to be produced in a day.

Each module accommodates a microfluidic chip with up to seven channels and, for maximum throughput, up to 10 modules can be linked to provide a total of 70 parallel channels; with tool-free module assembly and chip connection, set-up is rapid.

Telos features integrated valves for rapid start-up and individual chip control, and operates over a wide range of pressures and temperatures, from 0 to 10bar and 4 to 50°C, providing users with maximum flexibility.

The novel Mitos Dropix, developed in collaboration with the winner of Dolomite’s Productizing Science® Competition 2012, Drop-Tech Ltd, is a flexible, automated solution for droplet-on-demand applications.

Patented droplet ‘picking’ technology enables combinatorial droplet arrays to be created from multiple reagents off-chip and introduced into a flow-through microfluidic system, with accurate control of droplet size and frequency achieved via PC software.

This new high throughput screening format will prove an invaluable resource for basic research, drug discovery, cell-based studies and diagnostics applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos